NCT04518709

Brief Summary

The main problem in mitral valve repair surgery in children is the high number of postoperative residual lesions (49% of the total cases). Residual lesions after mitral valve repair are associated with morbidity and complications in the form of hemolysis and could affect the postoperative reverse remodeling process. Surgery techniques for mitral valve repair in children have fewer choices than adult patients because of the smaller and thinner valve structure. Besides, the weakness of the mitral valve repair technique that often occurs in large left ventricles with severe mitral regurgitation, after repairing with ring annuloplasty, there is usually a mild residual regurgitation due to posterior mitral leaflet that tends to become restrictive due to being attracted by the left ventricular wall that remains big. No technique has been found to overcome the problem of mitral regurgitation residuals that occur postoperatively. Therefore, by analyzing postoperative mitral valve structural abnormalities with conventional techniques, an additional posterior mitral valve elevation technique was designed to increase the area of coaptation between two leaves of the mitral valve so that the incidence of postoperative regurgitation lesions can be reduced.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2020

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 2, 2020

Completed
15 days until next milestone

Study Start

First participant enrolled

August 17, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 19, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 17, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 17, 2022

Completed
Last Updated

August 19, 2020

Status Verified

August 1, 2020

Enrollment Period

2 years

First QC Date

August 2, 2020

Last Update Submit

August 16, 2020

Conditions

Keywords

Posterior Annulus Elevation TechniquePediatric Mitral Valve Insufficiency

Outcome Measures

Primary Outcomes (5)

  • Residual mitral valve regurgitation

    Residual mitral valve regurgitation is measured using transesophageal echocardiography and transthoracic echocardiography

    5 days after surgery

  • Mitral valve coaptation area

    Mitral valve coaptation area is measured using transesophageal echocardiography and transthoracic echocardiography

    Intraoperative

  • Change of Haptoglobin at 3 months after surgery

    Serum haptoglobin level that indicated the presence of intravascular hemolysis is measured after the surgery

    Preoperative (baseline), 5 days, 2 weeks and 3 months after surgery

  • Change of Lactate dehydrogenase at 3 months after surgery

    Lactate dehydrogenase level that indicated the presence of intravascular hemolysis is measured after the surgery

    Preoperative (baseline), 5 days, 2 weeks and 3 months after surgery

  • Change of NT-proBNP at 3 months after surgery

    NTproBNP is a marker of acute heart failure and indicates the process of heart remodeling.

    Preoperative (baseline), 5 days, 2 weeks and 3 months after surgery

Study Arms (2)

Posterior Annulus Elevation Technique Group

EXPERIMENTAL

In patients who were determined in the treatment group, after the conventional procedure for mitral valve repair was completed, a posterior mitral valve elevation technique will be performed.

Procedure: Posterior Mitral Annulus Elevation Technique

Without Posterior Annulus Elevation Technique Group

PLACEBO COMPARATOR

No additional procedure will be done after conventional mitral valve repair

Procedure: Conventional Mitral Valve Repair

Interventions

Posterior mitral annulus elevation technique is performed using a large pledget and non-absorbable braided suture starting from the subvalvular section of the posterior mitral valve sutured to the ring annuloplasty (if in the process of repairing the mitral valve, ring implantation is performed; if without the use of ring annuloplasty, the suture is placed in the left atrial wall / supravalvular of PML), so that the posterior annulus is slightly attracted upward toward the cranial and the PML moves toward the center.

Posterior Annulus Elevation Technique Group

Conventional mitral valve repair in the pediatric patient using annuloplasty, leaflet resection and plication, sliding-plasty of chordae technique

Without Posterior Annulus Elevation Technique Group

Eligibility Criteria

Age1 Month - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients with mitral regurgitation heart disease.
  • Patients with an age range of 1 day - 18 years
  • Patients with mitral regurgitation heart disease with atrial septal defects
  • Mitral valve repair surgery performed by single surgeon (Budi Rahmat, MD)

You may not qualify if:

  • Patients refuse to participate in the study.
  • Having additional cardiac abnormalities other than atrial septal defects that change the surgery plan.
  • Reoperation mitral valve surgery.
  • History of abnormalities in the central nervous system / preoperative stroke.
  • Patients with severe pulmonary hypertension
  • Patients with small left ventricles (LV smallish)
  • History of pulmonary resuscitation (CPR) before surgery.
  • Dropout Criteria
  • The patient fails to complete the entire examination procedure.
  • Mitral regurgitation patients who are decided to do mitral valve replacement intra-operatively.
  • Using extracorporeal life support (ECMO) device after surgery.
  • History of intra-operative CPR.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Mitral Valve Insufficiency

Condition Hierarchy (Ancestors)

Heart Valve DiseasesHeart DiseasesCardiovascular Diseases

Central Study Contacts

Budi Rahmat, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief of Pediatric & Congenital Heart Surgery Division

Study Record Dates

First Submitted

August 2, 2020

First Posted

August 19, 2020

Study Start

August 17, 2020

Primary Completion

August 17, 2022

Study Completion

August 17, 2022

Last Updated

August 19, 2020

Record last verified: 2020-08